"Before COVID-19, Moderna was in danger of hemorrhaging investors, as persistent safety concerns and other doubts about its mRNA delivery system threatened its entire product pipeline. Fear caused by the pandemic crisis made those concerns largely evaporate, even though there is no proof that they were ever resolved." https://unlimitedhangout.com/2021/10/investigative-reports/moderna-a-company-in-need-of-a-hail-mary/
If somebody spends decent amount of his lifetime building a business no wonder he wants to squeeze some juice out of it finally. The quality of the final product can become subsidiary at that phase. I definitely won't be their customer
I think their best products that will soon catch the eye of their investors are Cancer Therapeutics. It wouldn't be surprising as a biotechnology company that their stock will split before it reaches the $500 dollar level from the current $349 price level. Nasdaq: MRNA wrbtrader
well it got the hail mary with covid, as it was able to create and distribute its vaccine successfully.
Why wouldn't one cash out when a share is worth ~$50 in the best dream. I wonder tho, how long will last their covi legacy. Will it be calculated into the brand like KO forever, or shall it slowly fade away & 20 years down the line, nobody will remember.
other than 25 million doses successfully delivered into U.S. arms with out outstanding results and safety. They are on track to produce 3 billion doses by sometime in 2022.